Anti-nmda Receptor Encephalitis

• CLINICAL_TRIALS research · 2026-04-03
  Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis [Phase 3]

  A Phase 3 clinical trial evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in participants with anti-N…

• CLINICAL_TRIALS research · 2026-02-17
  Clinical Trial Update: Long-term Impact of NMDAR Encephalitis, Level 3

  A Level 3 clinical trial assessing the long-term impact of anti-NMDA receptor encephalitis is currently recruiting.

• CLINICAL_TRIALS research · 2025-07-15
  Clinical Trial Update: Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis [Phase 3]

  A Phase 3 trial is evaluating the safety and efficacy of combining B cell–depleting therapy with Daratumumab for anti-NMDA receptor encephal…

• CLINICAL_TRIALS research · 2025-07-01
  Clinical Trial Update: The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis [Phase 2]

  A Phase 2 clinical trial called ExTINGUISH is evaluating Inebilizumab for Anti-NMDA receptor encephalitis and is currently recruiting.

• CLINICAL_TRIALS research · 2025-04-08
  Clinical Trial Update: A Case Report of NMDAR Encephalopathy

  This document reports a case of anti-NMDA receptor encephalitis associated with a mature teratoma, detailing clinical presentation and manag…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-04-08
  Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) [NA]

  A clinical trial evaluating the efficacy and safety of Calculus Bovis Sativus for adults with encephalitis, including viral and autoimmune f…

• CLINICAL_TRIALS research · 2024-05-06
  Clinical Trial Update: Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage [NA]

  This entry documents an ongoing clinical trial studying antibody-mediated NMDA receptor encephalitis, focusing on symptoms, biomarkers, and …

• CLINICAL_TRIALS research · 2015-09-29
  Clinical Trial Update: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

  This entry describes a multicenter, prospective clinical registry study of anti-NMDA receptor encephalitis in China, sponsored by Beijing To…

• CLINICAL_TRIALS research · 2015-05-13
  Clinical Trial Update: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area

  A multicenter prospective clinical registry study in Beijing investigating anti-NMDA receptor encephalitis.